Copyright
©The Author(s) 2019.
World J Hepatol. Aug 27, 2019; 11(8): 613-618
Published online Aug 27, 2019. doi: 10.4254/wjh.v11.i8.613
Published online Aug 27, 2019. doi: 10.4254/wjh.v11.i8.613
Table 1 Diseases associated to porto sinusoidal vascular liver disease
| Thrombophilia |
| Myeloproliferative neoplasm |
| Protein S or C deficiency |
| Antiphospholipid antibodies |
| Lupus anticoagulant |
| Factor V Leiden |
| Prothrombin mutation |
| Hematologic disease |
| Myeloproliferative neoplasm (polycythemia vera, chronic myelogenous leukaemia, essential thrombocythemia) |
| Myeloid metaplasia |
| Lymphoproliferative conditions (Hodgkin’s disease, non-Hodgkin’s lymphoma, chronic lymphocytic leukaemia and multiple myeloma) |
| Spherocytosis |
| Genetic disorders |
| Cystic fibrosis |
| Adams Oliver syndrome |
| Turner‘s disease |
| Autoimmune disease |
| Rheumatoid arthritis |
| Systemic lupus erythematosus |
| Systemic sclerosis |
| Scleroderma |
| Gut diseases |
| Celiac disease |
| Inflammatory bowel disease |
| Drug and toxics |
| Oxaliplatin |
| Azathioprine |
| 6-thioguanine |
| Arsenic |
| Busulfan |
| Cytosine arabinoside |
| Cyclophosphamide |
| Bleomycin |
| Chlorambucil |
| Doxyrubicin |
| Carmustine |
| Acquired and congenital immunodeficiency |
| Human immunodeficiency virus |
| Primary antibody-deficiency syndrome |
Table 2 Predisposing causes of portal vein thrombosis
| Systemic prothrombotic conditions | Recommended checks |
| Inherited | Resistance to activated C protein/molecular biology for |
| Factor V Leiden | G1691A polymorphism |
| Prothrombin gene mutation | Molecular biology for G20210A polymorphism |
| Protein C, protein S and antithrombin deficiency | Ratio with F II, V, VII or X after correction for vitamin K deficiency; family survey (recommended) |
| Acquired | |
| Antiphospholipid syndrome | Anticardiolipin ELISA; LLAC |
| Myeloproliferative neoplasm (MPN) | JAK2 and CALR mutations; osteomidullary biopsy |
| Paroxysomal nocturnal hemoglobinuria | Flow cytometry (deficient cells of CD55 and CD59) |
| Oral contraceptive use | Anamnesis |
| Obesity | BMI > 30 kg/m2 |
| CMV infection | CMV IgG, CMV IgM |
| Pregnancy | Beta-HCG, anamnesis |
| Celiac disease | Anti-transglutaminase IgA/IgG |
| Local prothrombotic conditions | Anamnesis and radiological examination |
| Surgery and trauma | |
| Umbilical cannulation | |
| Splenectomy, cholecystectomy | |
| Hepatic resection | |
| Abdominal trauma | |
| Bariatric surgery | |
| Portosystemic shunts including TIPS | Anamnesis and radiological examination |
| Inflammatory and infectious diseases | |
| Neonatal omphalitis | |
| Appendicitis, diverticulitis, pancreatitis | |
| Inflammatory bowel disease | |
| Cholecystitis, cholangitis | |
| Other | |
| Cirrhosis | |
| Porto sinusoidal vascular liver disease | |
- Citation: Gioia S, Nardelli S, Ridola L, d’Amati G, Riggio O. Is porto sinusoidal vascular disease to be actively searched in patients with portal vein thrombosis? World J Hepatol 2019; 11(8): 613-618
- URL: https://www.wjgnet.com/1948-5182/full/v11/i8/613.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i8.613
